Ekso Bionics (Nasdaq: EKSO), manufacturer of the Ekso Indego Personal exoskeleton, reported lower revenue numbers for its second quarter in a July 28 earnings call. “While there was abnormal weakness in the second quarter, in large part due to what we believe are short-term delays in completing some multi-device enterprise health sales, we are working…
Ekso Bionics ‘Working to Get Back on Track’ After Lower Second-Quarter Earnings Report
Briefly: Ekso Bionics Joins NVIDIA Connect Program; CRT Fly-In Dates Announced
Featuring Ekso Bionics, NCART, iNRRTS, and U.S. Rehab.
Ekso Bionics Accepted Into NVIDIA Connect Program to Accelerate Product Development Ekso Bionics Holdings (Nasdaq: EKSO) has been accepted into the NVIDIA Connect program, which helps software development companies and service providers to accelerate product development, improve cost efficiency, and shorten time to market. “The company plans to use the valuable tools and resources provided…
Ekso Bionics Q1 Earnings: Partnerships with NSM, Bionic P&O Expected to Grow Personal Health Products Segment This Year
National Seating & Mobility was announced as the exclusive CRT distributor of the Ekso Indego Personal exoskeleton in February.
New partnerships with national Complex Rehab Technology (CRT) and prosthetics/orthotics providers are expected to grow Ekso Bionics’ Personal Health Products segment for 2025, the company announced during its May 5 earnings call. Ekso Bionics (Nasdaq: EKSO) reported earnings results for the three months ending on March 31, 2025, while also commenting on what the company…